Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May -
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
- 2015 -
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
May 2015 - 19 products
IP
CI
CM
Rizatriptan-Mepha oro 5 mg
6 Tablet(s)
20.84
39.10
10 %
Melting tablets: Rizatriptanum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Rizatriptan-Mepha oro 10 mg
3 Tablet(s)
11.98
29.45
10 %
Melting tablets: Rizatriptanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Rizatriptan-Mepha oro 10 mg
6 Tablet(s)
20.84
39.10
10 %
Melting tablets: Rizatriptanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Rizatriptan-Mepha oro 10 mg
12 Tablet(s)
39.29
59.15
10 %
Melting tablets: Rizatriptanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Memantin Sandoz 10 mg
50 Tablet(s)
44.74
65.05
10 %
Coated tablets: Memantini Hydrochloridum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Memantin Sandoz 20 mg
98 Tablet(s)
166.52
197.50
10 %
Coated tablets: Memantini Hydrochloridum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
CM
Buprenorphin-Mepha 35ug/h
4
28.12
47.00
10 %
Transdermale Pflaster: Buprenorphinum 20 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
CM
Buprenorphin-Mepha 35ug/h
8
53.66
74.75
10 %
Transdermale Pflaster: Buprenorphinum 20 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
CM
Buprenorphin-Mepha 52.5
ug/h
4
38.46
58.25
10 %
Transdermale Pflaster: Buprenorphinum 30 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
CM
Buprenorphin-Mepha 52.5
ug/h
8
71.32
94.00
10 %
Transdermale Pflaster: Buprenorphinum 30 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
CM
Buprenorphin-Mepha 70
ug/h
4
50.70
71.55
10 %
Transdermale Pflaster: Buprenorphinum 40 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
CM
Buprenorphin-Mepha 70
ug/h
8
96.44
121.30
10 %
Transdermale Pflaster: Buprenorphinum 40 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Escitalopram Sandoz 20
mg/ml
15 ml
9.34
26.55
10 %
Tropfen zum Einnehmen: Escitalopramum 20 mg/ml
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
PP
Trulicity 0.75 mg
4 piece(s)
93.67
118.30
10 %
solution injectable stylo pré-remplie à usage unique: Dulaglutidum
Eli Lilly (Suisse) SA
● 
B / SL
FB
G
L
IP
CI
PP
Trulicity 1.5 mg
4 piece(s)
93.67
118.30
10 %
solution injectable stylo pré-remplie à usage unique: Dulaglutidum 1.5mg / 0.5ml
Eli Lilly (Suisse) SA
● 
B / SL
FB
G
IP
CI
Memantin Sandoz 5 mg
Kombipackung(en)
28.50
49.10
k.A.
Coated tablets: Memantini Hydrochloridum 5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Memantin Sandoz 15 mg
Kombipackung(en)
PR
PR
k.A.
Coated tablets: Memantini Hydrochloridum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
PP
Trulicity 3.0 mg
4
PR
PR
k.A.
solution injectable stylo pré-remplie à usage unique: Dulaglutidum 3mg / 0.5ml
Eli Lilly (Suisse) SA
B
FB
G
IP
PP
Trulicity 4.5 mg
4
PR
PR
k.A.
solution injectable stylo pré-remplie à usage unique: Dulaglutidum 4.5mg / 0.5ml
Eli Lilly (Suisse) SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home